CAMK2G and catecholaminergic polymorphic ventricular tachycardia: If this is the case, the prevention of CaMKII MM281/282 oxidation will not be protective in CPVT, as arrhythmias in CPVT occur in situations with increased β‐adrenoceptor activation (Wleklinski et al., 2020).